Background and aim The International Cancer of the Pancreas Screening Consortium met in
2018 to update its consensus recommendations for the management of individuals with …

Background Screening individuals at increased risk for pancreatic cancer (PC) detects early,
potentially curable, pancreatic neoplasia. Objective To develop consortium statements on …

Objective Surveillance programmes are recommended for individuals at risk (IAR) of familial
pancreatic cancer (FPC) to detect early pancreatic cancer (pancreatic ductal …

Description The purpose of this American Gastroenterological Association Institute Clinical
Practice Update is to describe the indications for screening for pancreas cancer in high-risk …

Background & Aims There have been few studies of abdominal imaging screening of
individuals at high risk for pancreatic cancer (based on family history or genetic variants) …

Importance Pancreatic cancer is the fourth leading cause of cancer-related death in Western
countries. In approximately 10% of all patients with pancreatic cancer, it is possible to define …

Background and Aims Pancreatic cancer (PC) is a deadly disease that is most commonly
diagnosed at an incurable stage. Different high-risk genetic variants and cancer syndromes …

Background: Nearly 10% of pancreatic cancers are hereditary in origin, and in some
individuals, the risk of pancreatic cancer approaches 50%. A number of defined syndromes …

Objective: Familial pancreatic cancer (FPC) accounts for approximately 3% of all pancreatic
cancer (PC) cases. It has been suggested that high-risk individuals (HRIs) should be offered …

OBJECTIVES: Pancreatic adenocarcinoma is a lethal disease. Over 80% of patients are
found to have metastatic disease at the time of diagnosis. Strategies to improve disease …